Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase EARLY_PHASE1 2Phase 3 2Phase NA 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Stomach Neoplasms 2Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Peritoneal Neoplasms 1Hyperthermia 1Gastrointestinal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Appendiceal Neoplasms 1

Interventions

Paclitaxel 45Carboplatin 33Bevacizumab 17liposomal doxorubicin 15Topotecan 12Taxes 10Gemcitabine 10Drug Therapy 6Cisplatin 6rucaparib 5mirvetuximab soravtansine 5Docetaxel 5Immunoglobulin G 4Doxorubicin 4Disulfides 4trebananib 3pembrolizumab 3olaparib 3Saline Solution 3Neoadjuvant Therapy 3Hyperthermic Intraperitoneal Chemotherapy 3Dexamethasone 3CP protocol 3niraparib 2cediranib 2Tamoxifen 2Specimen Handling 2Letrozole 2Glucose 2Cytoreduction Surgical Procedures 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Fallopian Tube Neoplasms × Cytoreduction Surgical Procedures × Clear all
NCT03373058 2019-11-06

EHTASEOCCS

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Phase 3 Unknown
310 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT02328716 2017-12-13

CARCINOHIPEC

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Phase 3 Unknown
32 enrolled
Gynecologic

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡